146 related articles for article (PubMed ID: 37097695)
1. Successful Prevention of Tumour Lysis Syndrome in HER2-positive Breast Cancer: Case Report and Literature Review.
Omori S; Shigechi T; Kawaguchi K; Ijichi H; Oki E; Yoshizumi T
Anticancer Res; 2023 May; 43(5):2371-2377. PubMed ID: 37097695
[TBL] [Abstract][Full Text] [Related]
2. Tumor lysis syndrome following trastuzumab for breast cancer: a case report and review of the literature.
Taira F; Horimoto Y; Saito M
Breast Cancer; 2015 Nov; 22(6):664-8. PubMed ID: 23420376
[TBL] [Abstract][Full Text] [Related]
3. Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report.
Baudon C; Duhoux FP; Sinapi I; Canon JL
J Med Case Rep; 2016 Jun; 10():178. PubMed ID: 27312594
[TBL] [Abstract][Full Text] [Related]
4. A case of disseminated intravascular coagulation following tumour lysis syndrome due to small cell carcinoma of the lung.
Takahashi S; Takehara T; Tani T; Ishioka K; Madoiwa S
Respirol Case Rep; 2023 Mar; 11(3):e01093. PubMed ID: 36776994
[TBL] [Abstract][Full Text] [Related]
5. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
Baeksgaard L; Sørensen JB
Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
[TBL] [Abstract][Full Text] [Related]
6. Tumor lysis syndrome associated with weekly paclitaxel treatment in a case with ovarian cancer.
Yahata T; Nishikawa N; Aoki Y; Tanaka K
Gynecol Oncol; 2006 Nov; 103(2):752-4. PubMed ID: 16857250
[TBL] [Abstract][Full Text] [Related]
7. Management of tumour lysis syndrome during first-line palliative chemotherapy for high-volume colorectal cancer.
Gouveia HS; Lopes SO; Faria AL
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29545434
[TBL] [Abstract][Full Text] [Related]
8. [Gemcitabine-induced tumor lysis syndrome caused by recurrent breast cancer in a patient without hemodialysis].
Kawaguchi Ushio A; Hattori M; Kohno N; Kaise H; Iwata H
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1529-32. PubMed ID: 24231708
[TBL] [Abstract][Full Text] [Related]
9. A review of tumour lysis syndrome with targeted therapies and the role of rasburicase.
Bose P; Qubaiah O
J Clin Pharm Ther; 2011 Jun; 36(3):299-326. PubMed ID: 21501203
[TBL] [Abstract][Full Text] [Related]
10. [Tumour lysis syndrome in small-cell lung cancer].
Boshuizen RC; Smit AA; Moons-Pasic A; Bresser P
Ned Tijdschr Geneeskd; 2016; 160():A9823. PubMed ID: 27334081
[TBL] [Abstract][Full Text] [Related]
11. Tumour lysis syndrome in a patient with intravascular spread from a recurrent epithelial ovarian cancer.
Camarata M; Davies R; Copley S; Blagden S
BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23616333
[TBL] [Abstract][Full Text] [Related]
12. Ixazomib-associated tumor lysis syndrome in multiple myeloma: A case report.
Jin F; Yang M; Chen Y; Jiang L; Liu L
Medicine (Baltimore); 2020 Nov; 99(45):e22632. PubMed ID: 33157919
[TBL] [Abstract][Full Text] [Related]
13. Febuxostat for management of tumor lysis syndrome including its effects on levels of purine metabolites in patients with hematological malignancies - a single institution's, pharmacokinetic and pilot prospective study.
Takai M; Yamauchi T; Ookura M; Matsuda Y; Tai K; Kishi S; Yoshida A; Iwasaki H; Nakamura T; Ueda T
Anticancer Res; 2014 Dec; 34(12):7287-96. PubMed ID: 25503162
[TBL] [Abstract][Full Text] [Related]
14. [A case of bone marrow carcinomatosis with disseminated intravascular coagulation arising from breast cancer successfully treated with paclitaxel plus bevacizumab].
Kawai H; Sugimoto R; Miyauchi S; Yoshida R; Waki N; Hirayama S; Ishizaki M; Nishi H; Yamashita K
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1957-9. PubMed ID: 25731388
[TBL] [Abstract][Full Text] [Related]
15. De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial.
Nitz U; Gluz O; Graeser M; Christgen M; Kuemmel S; Grischke EM; Braun M; Augustin D; Potenberg J; Krauss K; Schumacher C; Forstbauer H; Reimer T; Stefek A; Fischer HH; Pelz E; Zu Eulenburg C; Kates R; Wuerstlein R; Kreipe HH; Harbeck N;
Lancet Oncol; 2022 May; 23(5):625-635. PubMed ID: 35405088
[TBL] [Abstract][Full Text] [Related]
16. Tumor lysis syndrome in metastatic breast cancer after a single dose of paclitaxel.
Vaidya GN; Acevedo R
Am J Emerg Med; 2015 Feb; 33(2):308.e1-2. PubMed ID: 25178848
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and cost of single-dose rasburicase in prevention and treatment of adult tumour lysis syndrome: a meta-analysis.
Feng X; Dong K; Pham D; Pence S; Inciardi J; Bhutada NS
J Clin Pharm Ther; 2013 Aug; 38(4):301-8. PubMed ID: 23550846
[TBL] [Abstract][Full Text] [Related]
18. Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature.
Drakos P; Bar-Ziv J; Catane R
Am J Clin Oncol; 1994 Dec; 17(6):502-5. PubMed ID: 7977169
[TBL] [Abstract][Full Text] [Related]
19. Tumor Lysis Syndrome After a Single Dose of Atezolizumab with Nab-Paclitaxel: A Case Report and Review of Literature.
Carrier X; Gaur S; Philipovskiy A
Am J Case Rep; 2020 Sep; 21():e925248. PubMed ID: 32934194
[TBL] [Abstract][Full Text] [Related]
20. [HER2-Positive Advanced Gastric Cancer with Disseminated Intravascular Coagulation and Diffuse Bone Marrow Carcinomatosis Successfully Treated with S-1/Trastuzumab Chemotherapy--A Case Report].
Senoo S; Mannami T; Tamura T; Fujiwara N; Ikeda G; Komoda M; Ohtawa Y; Fujimoto Y; Sato N; Kambara T; Waku T; Kenmotsu M; Kurimoto E; Okada T; Harita S; Sonobe H
Gan To Kagaku Ryoho; 2015 Dec; 42(13):2471-5. PubMed ID: 26809307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]